Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62d1b8b0c95dc64dbe7e020d6c97f74f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-112 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-104 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate |
2003-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2008-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b05e84dde0c501fce7fba49eb8fddfbf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d73fdacef21579075da6680ec81dff2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef16db2874428901d5484db661060c26 |
publicationDate |
2008-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2325184-C2 |
titleOfInvention |
Improvement of bacteria outer membrane vesicle |
abstract |
FIELD: medicine; pharmacology. n SUBSTANCE: present method of bacteria outer membrane vesicle preparation of Neisseria bacteria implies destruction of bacteria shell and gathering of outer membrane vesicles at deoxycholate solution < 0.05%. Bacteria express surplus NspA. Invention allows to keep significant bacterial immunogenic components, specifically (i) protective surface protein NspA, (ii) protein '287' and (iii) protein '741'. n EFFECT: significant immunogenic components keeping. n 17 cl, 2 tbl, 2 dwg |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2607021-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9707286-B2 |
priorityDate |
2002-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |